FDA Gives Green Light to Phase 3 Trial of Buntanetap
Annovis Bio has been given the go-ahead by the U.S. Food and Drug Administration (FDA) to begin…
Articles by Patricia Inácio, PhD
Study Explores New Way to Monitor Neuroinflammation
Overactivation of microglia cells — known to drive neuroinflammation in diseases like Parkinson’s — can be detected by measuring a…
3-Month Boxing Program Found to Ease Motor, Nonmotor Symptoms
A tailored three-month boxing exercise program significantly eased both motor and nonmotor symptoms — including depression, anxiety, sleep problems, and…
Fujirebio Bolsters Its Parkinson’s Diagnostic Tools With Acquisition
Fujirebio Holdings’ portfolio of biomarkers and diagnostic tools for Parkinson’s disease now includes tailor-made antibodies against…
New LRRK2 Gene Mutations Linked With Familial Parkinson′s
Two new mutations in the LRRK2 gene have been identified as likely causes of familial Parkinson’s disease, a study reports.
Gut Microbiome of Patients Favors Inflammation, Study Suggests
People with Parkinson’s disease appear to have a gut microbiome — the population of microorganisms living in…
Dosing Begins in Phase 2b Study of Oral BIIB122/DNL151
A Phase 2b clinical trial evaluating the investigational oral therapy BIIB122/DNL151 for the treatment of people with Parkinson’s disease has started…
New Tiny Sensors Detect Dopamine in High Resolution in Nerve Cells
Scientists have developed tiny sensors that allow the high-resolution detection of dopamine — the brain chemical messenger progressively…
Immunotolerance Molecules Show Promise in Mouse Model of PD
Preclinical research supports the potential of small molecules that modulate the immune system to halt Parkinson’s disease (PD) progression…
Vocal Changes May Be Caused by Alpha-synuclein Clumps: Study
Insoluble clumps of the alpha-synuclein protein accumulating in the brain — a hallmark of Parkinson’s disease — can affect…